IL117591A0 - Synthetic DNA encoding human papillomavirus type 11 L1 protein - Google Patents

Synthetic DNA encoding human papillomavirus type 11 L1 protein

Info

Publication number
IL117591A0
IL117591A0 IL11759196A IL11759196A IL117591A0 IL 117591 A0 IL117591 A0 IL 117591A0 IL 11759196 A IL11759196 A IL 11759196A IL 11759196 A IL11759196 A IL 11759196A IL 117591 A0 IL117591 A0 IL 117591A0
Authority
IL
Israel
Prior art keywords
protein
synthetic dna
human papillomavirus
pct
papillomavirus type
Prior art date
Application number
IL11759196A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27022236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL117591(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL117591A0 publication Critical patent/IL117591A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL11759196A 1995-03-30 1996-03-21 Synthetic DNA encoding human papillomavirus type 11 L1 protein IL117591A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41357295A 1995-03-30 1995-03-30
US41357195A 1995-03-30 1995-03-30

Publications (1)

Publication Number Publication Date
IL117591A0 true IL117591A0 (en) 1996-07-23

Family

ID=27022236

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11759196A IL117591A0 (en) 1995-03-30 1996-03-21 Synthetic DNA encoding human papillomavirus type 11 L1 protein

Country Status (21)

Country Link
US (1) US6159729A (da)
EP (1) EP0817852B1 (da)
JP (1) JP3918877B2 (da)
KR (1) KR100441477B1 (da)
CN (1) CN1154732C (da)
AT (1) ATE247712T1 (da)
AU (1) AU708111B2 (da)
CZ (1) CZ291375B6 (da)
DE (1) DE69629556T2 (da)
DK (1) DK0817852T3 (da)
EA (1) EA000969B1 (da)
ES (1) ES2203691T3 (da)
HU (1) HU228490B1 (da)
IL (1) IL117591A0 (da)
NO (1) NO320086B1 (da)
NZ (1) NZ306663A (da)
PL (1) PL183299B1 (da)
PT (1) PT817852E (da)
SK (1) SK283998B6 (da)
WO (1) WO1996030520A2 (da)
ZA (1) ZA962526B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2177999C2 (ru) * 1994-09-22 2002-01-10 Мерк Энд Ко., Инк. Экспрессирующий вектор (варианты)
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
WO1998044944A2 (en) * 1997-04-08 1998-10-15 Merck & Co., Inc. Stabilized human papillomavirus formulations
EP1105466B1 (en) * 1998-08-14 2006-04-26 Merck & Co., Inc. Process for purifying human papillomavirus virus-like particles
DE19840263C1 (de) * 1998-09-03 2000-05-25 Deutsches Krebsforsch Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
US6380364B1 (en) 1998-11-23 2002-04-30 Loyola University Of Chicago Chimeric biotin-binding papillomavirus protein
AUPP765398A0 (en) * 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
ATE413188T1 (de) 1999-02-05 2008-11-15 Merck & Co Inc Menschliche papillomavirus impfstoff- formulierungen
US7001995B1 (en) * 1999-08-25 2006-02-21 Merck & Co., Inc. Synthetic human papillomavirus genes
EP1806410A3 (en) * 2001-08-23 2007-10-24 Merck & Co., Inc. Fluorescent multiplex HPV PCR assays using multiple fluorophores
EP1302550A1 (en) * 2001-10-10 2003-04-16 King Car Food Industrial Co., Ltd. Method and detector for identifying subtypes of human papilloma viruses
EP1603590A4 (en) * 2003-03-07 2008-08-27 Merck & Co Inc INFLUENZA VIRUS VACCINE
RU2356943C2 (ru) * 2003-03-24 2009-05-27 Мерк Энд Ко., Инк. Молекула нуклеиновой кислоты, кодирующая hpv31 l1, экспрессирующий вектор, клетка-хозяин, вирусоподобная частица и способ ее получения, вакцина, фармацевтическая композиция и способы с их использованием
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
JP4498357B2 (ja) 2003-09-25 2010-07-07 サード・ウェーブ・テクノロジーズ・インク Ｈｐｖの検出法
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
MY139500A (en) * 2003-11-12 2009-10-30 Merck Sharp & Dohme Optimized expression of hpv 58 l1 in yeast
ATE466022T1 (de) * 2004-03-24 2010-05-15 Merck Sharp & Dohme Optimierte expression von hpv-52-l1 in hefe
ATE476528T1 (de) 2004-12-08 2010-08-15 Gen Probe Inc Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
CN101341257B (zh) * 2004-12-10 2012-10-10 杰纳罗生物系统有限责任公司 使用核酸探针、微珠和荧光激活的细胞分选器(facs)检测人乳头状瘤病毒(hpv)
CA2629564C (en) * 2005-11-15 2014-04-22 Genoid Kft. Method of detecting pathogens
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
KR20090073987A (ko) * 2007-12-31 2009-07-03 정운원 인간유두종바이러스 유전자형 검사를 위한 프라이머, 프로브 및 이를 포함하는 ｄｎａ칩, 이의 검사 방법 및 검사 키트
CA2799205A1 (en) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes
WO2012065034A1 (en) 2010-11-12 2012-05-18 Merck Sharp & Dohme Corp. Enolase peptide conjugate vaccines against staphylococcus aureus
CN103717741B (zh) * 2011-06-15 2016-04-13 中央大学校产学协力团 用于提高人乳头瘤病毒l1蛋白产量的方法
US10513541B2 (en) 2015-12-04 2019-12-24 Xiamen University Mutant of L1 protein of human papillomavirus type 11
WO2020063724A1 (zh) * 2018-09-26 2020-04-02 厦门大学 一种人乳头瘤病毒51型l1蛋白的突变体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1359156B1 (en) * 1991-07-19 2007-03-07 University of Queensland Vaccine against Human Papillomavirus (Type 18)
DE69434383T2 (de) * 1993-03-09 2005-11-24 The University Of Rochester Herstellung von menschlichem papillomavirus hüllprotein und virus-ähnlichen teilchen

Also Published As

Publication number Publication date
HUP9801608A2 (hu) 1998-10-28
HUP9801608A3 (en) 1999-04-28
DK0817852T3 (da) 2003-11-24
KR19980703391A (ko) 1998-10-15
SK129397A3 (en) 1998-05-06
KR100441477B1 (ko) 2004-10-06
HU228490B1 (en) 2013-03-28
US6159729A (en) 2000-12-12
WO1996030520A3 (en) 1996-11-07
PT817852E (pt) 2003-12-31
CZ291375B6 (cs) 2003-02-12
JPH11503313A (ja) 1999-03-26
EP0817852A2 (en) 1998-01-14
NO320086B1 (no) 2005-10-24
EA199700281A1 (ru) 1998-04-30
EP0817852B1 (en) 2003-08-20
SK283998B6 (sk) 2004-07-07
WO1996030520A2 (en) 1996-10-03
PL183299B1 (pl) 2002-06-28
DE69629556D1 (de) 2003-09-25
ES2203691T3 (es) 2004-04-16
JP3918877B2 (ja) 2007-05-23
NZ306663A (en) 1999-10-28
CN1154732C (zh) 2004-06-23
EA000969B1 (ru) 2000-08-28
PL322588A1 (en) 1998-02-02
AU708111B2 (en) 1999-07-29
ATE247712T1 (de) 2003-09-15
NO974514D0 (no) 1997-09-29
AU5527796A (en) 1996-10-16
CZ309197A3 (cs) 1998-02-18
NO974514L (no) 1997-11-27
ZA962526B (en) 1996-09-04
CN1185810A (zh) 1998-06-24
DE69629556T2 (de) 2004-06-17

Similar Documents

Publication Publication Date Title
ZA962526B (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
BG100974A (en) Vaccines against papillomavirus
HUP9801639A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
MY132529A (en) Paroxetine hydrochloride anhydrate
NZ306009A (en) Medical database system, unique identifier assigned to files, machine readable version of identifier included in hard copies
HUP9802556A1 (hu) Eljárás és készítmény kötőszöveti kapcsolódások gyógyítására és helyreállítására
BG102616A (en) Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application
HUP9801116A3 (en) Item of clothing, especially disposable clothing for use once only
DE69519856D1 (de) Expression von albumin in hefe
NL300273I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
EP0982988A4 (en) IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS
MX9709398A (es) N-aril-1,2,4-triazolin-5-onas.
IL122606A (en) (S)-hydroxa-nitrile-lyase
CA2200582A1 (en) Dna encoding human papillomavirus type 6a
PL288833A1 (en) Method of purifying 1,1,1-tris/4'-hydroxyphenyl/ethane
ZA969645B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides.
AU5816396A (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
DE59611353D1 (de) Transketolase-verwandtes protein
DE59702821D1 (en) Dimethyl-substituierte cyclohexandienderivate
ES2191785T3 (es) Proteina de accion antitumoral.
FR2664599B1 (fr) Vinylsulfonyl pristinamycine et sa preparation.
HK1009465A (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired